Bevacizumab in Stage II-III Colon Cancer: 5-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 TrialALLEGRA, Carmen J; YOTHERS, Greg; O'CONNELL, Michael J et al.Journal of clinical oncology. 2013, Vol 31, Num 3, pp 359-364, issn 0732-183X, 6 p.Article

Primary mFOLFOX6 Plus Bevacizumab Without Resection of the Primary Tumor for Patients Presenting With Surgically Unresectable Metastatic Colon Cancer and an Intact Asymptomatic Colon Cancer: Definitive Analysis of NSABP Trial C-10MCCAHILL, Laurence E; YOTHERS, Greg; WAGMAN, Lawrence D et al.Journal of clinical oncology. 2012, Vol 30, Num 26, pp 3223-3228, issn 0732-183X, 6 p.Article

Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon CancerALLEGRA, Careen J; YOTHERS, Greg; FEHRENBACHER, Louis et al.Journal of clinical oncology. 2009, Vol 27, Num 20, pp 3385-3390, issn 0732-183X, 6 p.Article